BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Seattle - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Seattle
X-ORIGINAL-URL:https://scienceinseattle.com
X-WR-CALDESC:Events for Science in Seattle
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210223T090000
DTEND;TZID=America/Vancouver:20210223T103000
DTSTAMP:20260504T074340
CREATED:20210201T181532Z
LAST-MODIFIED:20210201T181532Z
UID:11329-1614070800-1614076200@scienceinseattle.com
SUMMARY:Progress on the Pandemic: A Year of Tackling COVID-19
DESCRIPTION:Fred Hutch is at the center of a nonstop scientific sprint to understand and stop the coronavirus. Join us Tuesday\, February 23\, for Science Says\, our monthly researcher roundtable\, to meet scientists who are leading vaccine trials\, guiding public health policy\, tracking genetic changes to the virus\, and studying new treatments for COVID-19. \nPlease  RSVP by Monday\, February 22. After you register\, you will receive instructions for how to join the conversation by computer\, tablet\, or phone. \n\n\nSpeakers\n\n\n\n\n\n\n\n\n\nDr. Thomas J. Lynch Jr.\n\n\nDr. Thomas J. Lynch Jr.\, who will lead the conversation\, is Fred Hutch president and holder of the Raisbeck Endowed Chair. He is a lung cancer physician and scientist who is respected worldwide for his pioneering role in precision medicine and his leadership in academic medicine and industry. He joined Fred Hutch one year ago — just weeks before COVID-19 shutdowns began — and has guided the organization’s response to the pandemic with urgency\, compassion\, and a commitment to sparking scientific solutions. \n\n\n\n\n\n\n\nDr. Michele Andrasik\n\n\nDr. Michele Andrasik is one of the directors of the COVID-19 Prevention Network (CoVPN)\, which is conducting Phase 3 efficacy trials for vaccines as part of Operation Warp Speed. She has worked to ensure that communities hit hardest by COVID-19 are adequately represented in vaccine trials\, and she helps create educational materials to increase understanding and uptake of approved vaccines. \n\n\n\n\n\n\n\nDr. Trevor Bedford\n\n\nDr. Trevor Bedford is a computational biologist who has been at the forefront of tracking the virus that causes COVID-19 since it emerged. His expertise and insight\, along with the software tool he co-developed\, Nextstrain\, have been instrumental to understanding the rapid spread and evolution of the coronavirus — and have earned him nearly 300\,000 followers on Twitter. \n\n\n\n\n\n\n\nDr. Larry Corey\n\n\nDr. Larry Corey is a world-renowned virologist\, principal investigator of the HIV Vaccine Trials Network\, and Fred Hutch president and director emeritus. As head of the COVID-19 Prevention Network operations center\, located at Fred Hutch\, and co-leader of the network’s massive clinical trials program\, he plays a critical role in Operation Warp Speed\, the nation’s monumental effort to develop\, test\, and distribute vaccines in record time. \n\n\n\n\n\n\n\nDr. Josh Schiffer\n\n\nDr. Josh Schiffer is an infectious disease physician who uses computer modeling to study COVID-19 transmission and super-spreading. His research has reinforced the importance of widespread masking and testing\, and he is a strong advocate for developing treatments that interrupt COVID-19 early in the course of infection. Dr. Schiffer is one of many researchers leading clinical trials at Fred Hutch’s new COVID-19 Clinical Research Center.
URL:https://scienceinseattle.com/event/progress-on-the-pandemic-a-year-of-tackling-covid-19/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210223T090000
DTEND;TZID=America/Vancouver:20210223T103000
DTSTAMP:20260504T074340
CREATED:20210201T181532Z
LAST-MODIFIED:20210201T181532Z
UID:25665-1614070800-1614076200@scienceinseattle.com
SUMMARY:Progress on the Pandemic: A Year of Tackling COVID-19
DESCRIPTION:Fred Hutch is at the center of a nonstop scientific sprint to understand and stop the coronavirus. Join us Tuesday\, February 23\, for Science Says\, our monthly researcher roundtable\, to meet scientists who are leading vaccine trials\, guiding public health policy\, tracking genetic changes to the virus\, and studying new treatments for COVID-19. \nPlease  RSVP by Monday\, February 22. After you register\, you will receive instructions for how to join the conversation by computer\, tablet\, or phone. \n\n\nSpeakers\n\n\n\n\n\n\n\n\n\nDr. Thomas J. Lynch Jr.\n\n\nDr. Thomas J. Lynch Jr.\, who will lead the conversation\, is Fred Hutch president and holder of the Raisbeck Endowed Chair. He is a lung cancer physician and scientist who is respected worldwide for his pioneering role in precision medicine and his leadership in academic medicine and industry. He joined Fred Hutch one year ago — just weeks before COVID-19 shutdowns began — and has guided the organization’s response to the pandemic with urgency\, compassion\, and a commitment to sparking scientific solutions. \n\n\n\n\n\n\n\nDr. Michele Andrasik\n\n\nDr. Michele Andrasik is one of the directors of the COVID-19 Prevention Network (CoVPN)\, which is conducting Phase 3 efficacy trials for vaccines as part of Operation Warp Speed. She has worked to ensure that communities hit hardest by COVID-19 are adequately represented in vaccine trials\, and she helps create educational materials to increase understanding and uptake of approved vaccines. \n\n\n\n\n\n\n\nDr. Trevor Bedford\n\n\nDr. Trevor Bedford is a computational biologist who has been at the forefront of tracking the virus that causes COVID-19 since it emerged. His expertise and insight\, along with the software tool he co-developed\, Nextstrain\, have been instrumental to understanding the rapid spread and evolution of the coronavirus — and have earned him nearly 300\,000 followers on Twitter. \n\n\n\n\n\n\n\nDr. Larry Corey\n\n\nDr. Larry Corey is a world-renowned virologist\, principal investigator of the HIV Vaccine Trials Network\, and Fred Hutch president and director emeritus. As head of the COVID-19 Prevention Network operations center\, located at Fred Hutch\, and co-leader of the network’s massive clinical trials program\, he plays a critical role in Operation Warp Speed\, the nation’s monumental effort to develop\, test\, and distribute vaccines in record time. \n\n\n\n\n\n\n\nDr. Josh Schiffer\n\n\nDr. Josh Schiffer is an infectious disease physician who uses computer modeling to study COVID-19 transmission and super-spreading. His research has reinforced the importance of widespread masking and testing\, and he is a strong advocate for developing treatments that interrupt COVID-19 early in the course of infection. Dr. Schiffer is one of many researchers leading clinical trials at Fred Hutch’s new COVID-19 Clinical Research Center.
URL:https://scienceinseattle.com/event/progress-on-the-pandemic-a-year-of-tackling-covid-19-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20210223T090000
DTEND;TZID=America/Vancouver:20210223T103000
DTSTAMP:20260504T074340
CREATED:20210201T181532Z
LAST-MODIFIED:20210201T181532Z
UID:26630-1614070800-1614076200@scienceinseattle.com
SUMMARY:Progress on the Pandemic: A Year of Tackling COVID-19
DESCRIPTION:Fred Hutch is at the center of a nonstop scientific sprint to understand and stop the coronavirus. Join us Tuesday\, February 23\, for Science Says\, our monthly researcher roundtable\, to meet scientists who are leading vaccine trials\, guiding public health policy\, tracking genetic changes to the virus\, and studying new treatments for COVID-19. \nPlease  RSVP by Monday\, February 22. After you register\, you will receive instructions for how to join the conversation by computer\, tablet\, or phone. \n\n\nSpeakers\n\n\n\n\n\n\n\n\n\nDr. Thomas J. Lynch Jr.\n\n\nDr. Thomas J. Lynch Jr.\, who will lead the conversation\, is Fred Hutch president and holder of the Raisbeck Endowed Chair. He is a lung cancer physician and scientist who is respected worldwide for his pioneering role in precision medicine and his leadership in academic medicine and industry. He joined Fred Hutch one year ago — just weeks before COVID-19 shutdowns began — and has guided the organization’s response to the pandemic with urgency\, compassion\, and a commitment to sparking scientific solutions. \n\n\n\n\n\n\n\nDr. Michele Andrasik\n\n\nDr. Michele Andrasik is one of the directors of the COVID-19 Prevention Network (CoVPN)\, which is conducting Phase 3 efficacy trials for vaccines as part of Operation Warp Speed. She has worked to ensure that communities hit hardest by COVID-19 are adequately represented in vaccine trials\, and she helps create educational materials to increase understanding and uptake of approved vaccines. \n\n\n\n\n\n\n\nDr. Trevor Bedford\n\n\nDr. Trevor Bedford is a computational biologist who has been at the forefront of tracking the virus that causes COVID-19 since it emerged. His expertise and insight\, along with the software tool he co-developed\, Nextstrain\, have been instrumental to understanding the rapid spread and evolution of the coronavirus — and have earned him nearly 300\,000 followers on Twitter. \n\n\n\n\n\n\n\nDr. Larry Corey\n\n\nDr. Larry Corey is a world-renowned virologist\, principal investigator of the HIV Vaccine Trials Network\, and Fred Hutch president and director emeritus. As head of the COVID-19 Prevention Network operations center\, located at Fred Hutch\, and co-leader of the network’s massive clinical trials program\, he plays a critical role in Operation Warp Speed\, the nation’s monumental effort to develop\, test\, and distribute vaccines in record time. \n\n\n\n\n\n\n\nDr. Josh Schiffer\n\n\nDr. Josh Schiffer is an infectious disease physician who uses computer modeling to study COVID-19 transmission and super-spreading. His research has reinforced the importance of widespread masking and testing\, and he is a strong advocate for developing treatments that interrupt COVID-19 early in the course of infection. Dr. Schiffer is one of many researchers leading clinical trials at Fred Hutch’s new COVID-19 Clinical Research Center.
URL:https://scienceinseattle.com/event/progress-on-the-pandemic-a-year-of-tackling-covid-19-3/
LOCATION:Online
END:VEVENT
END:VCALENDAR